News & Updates

Show Multimedia Only

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023 by

Viral suppression is maintained through 48 weeks in adults with HIV-1 harbouring drug resistance mutations, who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) fixed-dose combination pill from a boosted protease inhibitor (bPI) therapy, according to recent data from the phase IV open-label PIBIK trial.

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

The respiratory system is the main target of human rhinovirus/enterovirus (HRV/EV) infections, which show a clinical course with low mortality rates, reveals a study.

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

28 Nov 2023 by

In the CONFIDENT trial, convalescent plasma (CCP) conferred a mortality benefit for patients with COVID-19-induced acute respiratory distress syndrome (ARDS) who were on invasive mechanical ventilation (IMV).

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

28 Nov 2023

Do children with HRV/EV fare better than those with other respiratory viruses?

27 Nov 2023

Children who test positive for human rhinovirus/enterovirus (HRV/EV) require close monitoring by clinicians, given possible clinical outcomes that are either similar or worse than known highly pathogenic viruses, suggests a recent study.

Do children with HRV/EV fare better than those with other respiratory viruses?

27 Nov 2023

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023 by

A systematic review and meta-analysis by researchers from the University of Hong Kong has shown that the use of peripherally inserted central catheters (PICCs) is associated with a higher rate of complications than central lines in terminally ill cancer patients with central venous access devices (CVADs) for palliative care. No conclusions were reached regarding the use of totally implanted ports (PORTs), as no studies on PORTs were eligible for analysis.

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

27 Nov 2023

HBV vaccine improves survival of patients with chronic liver disease

22 Nov 2023 by

Vaccination against hepatitis B virus (HBV) results in meaningful improvements in survival among patients with different kinds of chronic liver diseases, suggests a study presented at AASLD 2023.

HBV vaccine improves survival of patients with chronic liver disease

22 Nov 2023

Saline rinses may help prevent COVID-19 hospitalization

22 Nov 2023 by

A study presented at ACAAI 2023 demonstrated the potential of simple home remedies such as gargling and nasal rinsing with saltwater in cutting COVID-19 hospitalization rates.

Saline rinses may help prevent COVID-19 hospitalization

22 Nov 2023

Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours

21 Nov 2023

Diagnoses of invasive cutaneous melanoma in the year 2020 are characterized by thicker, more ulcerated, and more advanced tumours, a recent study has found. Of note, a 2020 diagnosis is not associated with survival.

Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours

21 Nov 2023

Bulevirtide-PegIFNα combo yields benefits for CHD patients

21 Nov 2023 by

A combination regimen comprising bulevirtide 10 mg (BLV10) and pegylated interferon alpha-2a (PegIFNα) improved multiple liver parameters in patients with chronic hepatitis delta (CHD), findings from the phase IIb MYR204 study have shown.

Bulevirtide-PegIFNα combo yields benefits for CHD patients

21 Nov 2023

Remdesivir, favipiravir may not be heart-friendly

20 Nov 2023 by

Remdesivir and favipiravir does not appear to be heart-friendly in patients with COVID-19, according to a study presented at APSR 2023.

Remdesivir, favipiravir may not be heart-friendly

20 Nov 2023

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

HRV/EV infections affect the respiratory system, yield low mortality rates

HRV/EV infections affect the respiratory system, yield low mortality rates

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

Convalescent plasma cuts death in mechanically ventilated patients with COVID-19-induced ARDS

Do children with HRV/EV fare better than those with other respiratory viruses?

Do children with HRV/EV fare better than those with other respiratory viruses?

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

Palliative care in cancer: Which central venous access devices are associated with higher complication rates?

HBV vaccine improves survival of patients with chronic liver disease

HBV vaccine improves survival of patients with chronic liver disease

Saline rinses may help prevent COVID-19 hospitalization

Saline rinses may help prevent COVID-19 hospitalization

Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours

Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours

Bulevirtide-PegIFNα combo yields benefits for CHD patients

Bulevirtide-PegIFNα combo yields benefits for CHD patients

Remdesivir, favipiravir may not be heart-friendly

Remdesivir, favipiravir may not be heart-friendly